Ilaria Campo Ph.D.

Dr. Ilaria Campo is a Senior Biologist (Consultant Level) in the Pathology and Molecular Genetics Unit and Pneumology Unit at Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. With more than 20 years of experience in molecular genetics, rare respiratory diseases, and translational clinical research, Dr. Campo has developed internationally recognized expertise in the genetic and molecular characterization of interstitial lung diseases (ILDs), with a particular focus on Pulmonary Alveolar Proteinosis (PAP) and Idiopathic Pulmonary Fibrosis (IPF).

After earning a Ph.D. in Genetic and Biomolecular Sciences and a Specialization in Clinical Pathology and Clinical Biochemistry from the University of Pavia, Dr. Campo established a research program focused on integrating molecular diagnostics and precision medicine into the clinical management of rare lung diseases. She serves as an Expert Member of the ClinGen Consortium-Pulmonary Working Group and is a member of the Genetic Working Group of ERN-LUNG (European Reference Network for Rare Respiratory Diseases). She also serves on the Technical-Scientific Committee of Fondazione IRCCS Policlinico San Matteo and as Secretary of the it’s Working Group on Research Integrity. Dr. Campo co-founded EuPAPNet, the European Network for Alveolar Proteinosis and contributed to the European Respiratory Society Clinical Practice Guidelines on Pulmonary Alveolar Proteinosis. She has extensive experience in multicenter clinical trials, including the IMPALA and IMPALA-2 clinical trials evaluating inhaled molgramostim in autoimmune PAP and currently leads the Italian National Registry of Pulmonary Alveolar Proteinosis.